J. Collins (Rotterdam, Netherlands), R. Rottier (Rotterdam, Netherlands)
Bone morphogenetic protein 9 protects against neonatal hyperoxia-induced impairment of lung development, inflammation and fibrosis.
G. Wagenaar (Leiden, Netherlands)
|  |
Tenascin C knockout mice have an altered lung function at newborn and adult age
T. Cremona (Bern, Switzerland)
| |
Mesenchymal Tsc2 deficiency causes retarded lung alveolarization and polycystic kidney lesion
S. Ren (Los Angeles, United States of America)
| |
Fgfr2b signaling in Alveolar Epithelial type II cells following pneumonectomy in mice
N. Ahmadvand (Giessen, Germany)
| |
IL-6-FOXO1 signaling as a novel mediator of metabolic programming of bronchial smooth muscle hypertrophy and asthma-like lung disease
M. Alejandre Alcázar (Köln, Germany)
| |
Novel functional role of GH/IGF1 axis in neonatal lung fibroblasts is linked to lung growth after intrauterine growth restriction
M. Alejandre Alcázar (Köln, Germany)
| |
The role of FoxO transcription factors in normal and aberrant late lung development
F. Palumbo (Gießen , Germany)
| |
Maternal interleukin-5 and/or eosinophils affect airway physiology of offspring
K. Lebold (Portland, United States of America)
| |
The impact of caffeine on TGF-ß signaling and brochopulmonary dysplasia
P. Rath (Bad Nauheim, Germany)
| |
Characterization of pulmonary TCF21 positive cells during neo-alveolarisation
J. Rodriguez-Castillo (Bad Nauheim, Germany)
| |
Mesenchymal lineage formation in the lung during development and disease
E. El Agha (Giessen, Germany)
| |